SCHEMBL27434007

SCHEMBL27434007

CCN1CCOc2c1cc(Cl)c(F)c2C(=O)OC

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38
ENPP2 Q13822 1/20 0.37
PTGER3 P43115 3/20 0.37
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
TSHR P16473 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NOTUM Q6P988 1/20 0.34
ALDH1A1 P00352 2/20 0.34
HSD17B10 Q99714 2/20 0.34
GAA P10253 1/20 0.34
ALOX15 P16050 1/20 0.34
EGFR P00533 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NR3C1 P04150 1/20 0.33
PGR P06401 1/20 0.33
AR P10275 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30954142 1.00 CHRM5 (0.38) CHRM5CHRM1CHRM3ENPP2PTGER3
SCHEMBL30954089 0.91 ENPP2 (0.36) CHRM5CHRM1CHRM3ENPP2LMNA
SCHEMBL27434153 0.91 ENPP2 (0.36) CHRM5CHRM1CHRM3ENPP2LMNA
SCHEMBL27435327 0.88 DRD2 (0.40) PTGER3LMNAHSD17B10KDM4E
SCHEMBL27434015 0.88 CHRM1 (0.37) CHRM5CHRM1CHRM3PTGER3LMNA
SCHEMBL30954157 0.88 CHRM1 (0.37) CHRM5CHRM1CHRM3PTGER3LMNA
SCHEMBL30954129 0.86 HTR4 (0.36) CHRM5CHRM3ENPP2LMNAMAPT
SCHEMBL27434031 0.86 HTR4 (0.36) CHRM5CHRM3ENPP2LMNAMAPT
SCHEMBL30954122 0.85 P2RX7 (0.36) CHRM5CHRM3ENPP2GAA
SCHEMBL30954098 0.85 ENPP2 (0.37) CHRM5CHRM3ENPP2LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024121130-A1 COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2024-06-13 WO disclosed